Shire

Ireland
Dublin, Leinster, Ireland, 24

Company profile

Shire company profile

Shire is the leading global biotechnology company focused on serving people with rare diseases. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. At Shire, the company ground everything they do in their purpose of enabling people with life altering conditions to lead better lives. The company's patient and customer focused culture encourages employees to embrace innovation and challenge the status quo through respectful and inclusive engagement with colleagues. Honesty and transparency are inherent in all that we do as we work with a high sense of urgency to become a leading global biotech delivering innovative therapies to patients with rare diseases and other specialty conditions. We foster an environment where leaders are positive, accountable, results driven and great people managers. Our employees own their development in partnership with their manager, understand and leverage their strengths, bring their whole selves to work, and like the leaders they are expected to eventually become, share the essential traits of positive, accountable and results driven. Our non-hierarchical structure and clear reporting lines enable quick decision making, nimble execution and the opportunity for employees to enjoy the work and grow to their fullest potential. The company is committed to recruit, develop and retain top talent who take a responsible and ethical approach to all that we do and who want to make a difference in the lives of patients across the globe.

Business identity

Phone number
+353 1 429 7700
Operating status
Closed
Company type
For Profit
Employee range
10,001+ employees
Revenue range
$10M+
Founded
1986-01-01, Year

Headquarters

Postal code
24
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Last funding
Series Unknown / 1987-01-01
Last equity funding
Series Unknown
Founders
1
Articles
193
Closed on
2013-04-05
Exited on
1996-02-16

Founders and investors

Founders

Harry Stratford